Health · NYSE ARCA · USD · Data as of 2026-07-30
AUM
$11.03M
Expense ratio
0.55%
Yield
0.26%
YTD return
+1.45%
Last price
$31.22
Thematic Sector · Coverage 100% · medium
Today
38.0
Outlook
45.1
Block A (composite-derived)
45.4
Block C (market behavior)
31.2
Today overlay (Block D)
0.0
Outlook overlay (Block D)
0.0
today_score = clip(0,100, 50 + 0.15·(A−50) + 0.60·(C−50) + D_today). Block B (holdings rollup) is in Phase 3 development; β=0 caps the natural range at ~12.5–87.5 in Preview v0.9. Formula version tide-etf-v1.0.0.
45.4
Coverage 100% · high
Liquidity
12.2
Expenses
65.0
Performance
23.6
Volatility
63.2
Dividend
2.9
Concentration
40.0
Smart Money
69.6
Activist
95.7
Formula version composite-v1.0.0. Axes hover to see why a sub-score is missing.
BlackRock Future Health ETF (BMED) is an exchange-traded fund from BlackRock in the Mixed asset class. Launched in 2020. Assets under management: 10,095,124.
Bullish Whales composite rating: 45 out of 100. Evidence coverage 100% across 8 of 8 axes. Strongest axes: activist exposure, smart-money flow, expenses.
Annualized one-year realized volatility 15%, classified moderate. Weakest axes: dividend, liquidity.
Top-10 weight 0%, diversified, led by JNJ.
etf_composite_score_current · activist_score, composite_score, confidence, coverage_pct, dividend_score, expenses_score, liquidity_score, smart_money_scoreetf_holdings_top10 · holding_symbol, weightetf_universe · asset_class, aum_usd, fund_type, inception_date, issuer, name, ticker, volatility_1yiShares Health Innovation A ETF is an exchange-traded fund that focuses on investing in companies at the forefront of innovation within the health and life sciences sectors. This ETF is constructed to provide exposure to companies that are pioneering advancements in healthcare technology, pharmaceuticals, medical devices, and biotechnology. The primary function of iShares Health Innovation A ETF is to offer investors a diversified portfolio of sector-leading firms that are driving the evolution of healthcare through technological advancements and research breakthroughs. This fund targets industries that have significant impacts on global health outcomes, catering to an ever-evolving demand for improved medical treatments and healthcare solutions. Companies within this ETF are typically involved in developing cutting-edge therapies and medical technologies steeped in innovation, addressing some of the most critical health challenges worldwide. As the healthcare industry undergoes continuous transformation powered by innovation and technological integration, iShares Health Innovation A ETF plays a crucial role in capturing these developments, offering investors a strategic way to engage with emerging growth opportunities within the healthcare landscape.
30-day change
$685.3K
90-day change
—
Current AUM: $11,030,106. AUM change is computed from rolling daily fundamentals snapshots; it reflects total net-asset deltas (creations/redemptions + market value moves), not pure share creations.
Fund documents (fact sheets, prospectuses, semi-annual reports) for BMED are coming soon. The BW fund-document archive will surface PDFs alongside a metadata index for searchability.